Pfizer and BioNTech recently announced that its COVID-19 vaccine, BNT162b2, demonstrated 100 percent efficacy and robust antibody responses in adolescents with or without prior SARS-CoV-2...
A new CDC study used real-world evidence to find that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections among healthcare personnel, first responders, and other essential...
A recent JAMA Network Open study found that there are distinct COVID-19 antibody response profiles that vary based on age.
The cross-sectional study used 31,426 COVID-19 antibody test results from...
Moderna recently announced that the first participants were dosed in the Phase 2/3 study of its COVID-19 vaccine candidate, mRNA-1273, in children six months to up to 12 years of age.
The study,...
A recent study found that COVID-19 antigen test sensitivity is higher in individuals with signs and symptoms of the coronavirus, rather than in those without symptoms present.
In individuals...
AstraZeneca recently announced that its COVID-19 vaccine was 76 percent effective against the coronavirus and 100 percent effective at preventing severe disease and hospitalization in a Phase 3...
FDA recently granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1) COVID-19 diagnostic test.
BioFire RP2.1 is used for the simultaneous qualitative detection of multiple...
Eli Lilly & Company recently announced new data showing that its combination COVID-19 antibody therapy significantly reduced COVID-19 hospitalizations and deaths in high-risk coronavirus...
A recent Pew Charitable Trusts study found that over half (52 percent) of COVID-19 hospitalizations during the first six months of the pandemic included antibiotic...
The Federal Trade Commission (FTC) recently launched a working group to update its approach to analyzing the effects of pharmaceutical mergers and acquisitions.
The joint project will adopt...
Vir Biotechnology and GlaxoSmithKline (GSK) are stopping a Phase 3 clinical trial of its COVID-19 antibody early after data shows “profound efficacy,” according to a recent announcement...
The Israel Ministry of Health (MoH), Pfizer, and BioNTech recently shared real-world evidence showing that the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, elicited lower incidence rates of coronavirus...
The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) recently reaffirmed the benefits of AstraZeneca’s COVID-19 vaccine.
The agencies stated that...
In an official letter to President Joe Biden, PhRMA and over 30 leaders in the biopharmaceutical warned that eliminating intellectual property (IP) protections in COVID-19 vaccine development could...
FDA recently issued an emergency use authorization for a sequencing-based COVID-19 diagnostic test.
The T-Detect COVID Test, developed by Adaptive Biotechnologies, is intended to identify individuals...
FDA recently issued an emergency use authorization for an at-home and over-the-counter (OTC) COVID-19 diagnostic test.
The Cue COVID-19 Test for Home and OTC Use test is a molecular nucleic acid...
GE Research and a multi-disciplinary team are receiving up to $41 million over the next five years to boost nucleic acid-based vaccine manufacturing and distribution.
The Defense Advanced...
Eli Lilly & Company recently announced that the US government has agreed to purchase a minimum of 100,000 doses of its COVID-19 antibody therapy combination for $210 million.
The COVID-19...
The Biden Administration recently announced a historic collaboration between Johnson & Johnson and Merck to expand production of Johnson & Johnson’s COVID-19 vaccine,...
AstraZeneca recently announced that the first doses of its COVID-19 vaccine through the COVAX initiative have begun arriving in low and middle-income countries globally.
The first shipments were...
